Effects of Pilates Method and Aerobic Training in Hypertensive Subjects

Not Applicable

Completed

• Conditions: Hypertension
• Interventions: Other: Aerobic Exercise; Other: Pilates

• Registration Number: NCT03214016
• Lead Sponsor: Universidade Federal de Santa Maria

Brief Summary

This study evaluates the effects of Pilates method and aerobic training in hypertensive subjects. Half of participants will be trained with Pilates, while the other half will be trained with aerobic exercise during 8 weeks.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2017-07-03
• Study First Submitted QC: 2017-07-09
• Study First Posted: 2017-07-11
• Study Start: 2017-08-20
• Primary Completion: 2018-05-30
• Study Completion: 2018-08-31
• Status Verified: 2020-04
• Last Update Submitted: 2020-04-29
• Last Update Posted: 2020-05-01

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 30

Inclusion Criteria

• subjects with high blood pressure controled by medication;
• sedentary.

Exclusion Criteria

• IMC≥30 kg/m²
• using beta blockers
• smokers or that interrupted the routine less than 6 months
• musculoskeletal diseases in evolution or with current symptomatic
• rheumatological diseases
• other cardiovascular disease
• renal disease due to hypertension
• endocrine, neurological, oncological, immunological, hematological and psychiatric diseases.

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Aerobic training group	Aerobic Exercise	The participants will do aerobic exercise on treadmill.
Pilates method group	Pilates	The participants will do Mat Pilates.

Primary Outcome Measures

Name	Time	Method
Change from baseline 24-hour systolic blood pressure at 8 weeks	baseline and 8 weeks	It will be evaluated by 24-hour ambulatory BP monitoring (ABPM)
Change from baseline casual systolic blood pressure at 8 weeks	baseline and 8 weeks	It will be evaluated with oscillometric method of measuring blood pressure with an automated cuff.

Secondary Outcome Measures

Name	Time	Method
Inflammation	baseline and 8 weeks	It will be evaluated by C-reactive protein in blood analysis
Creatine kinase	baseline and 8 weeks	By blood analysis
Casual diastolic blood pressure	baseline and 8 weeks	It will be evaluated with oscillometric method of measuring blood pressure with an automated cuff.
Questionnaire of Quality of life	baseline and 8 weeks	It will be evaluated by Mini-questionnaire of Quality of Life in Hypertension (MINICHAL)
Lipid profile	baseline and 8 weeks	By blood analysis (LDL, HDL, total cholesterol, glucose and triglycerides).
Creatinine	baseline and 8 weeks	By blood analysis
Lactate	baselina and 8 weeks	By blood analysis
Heart rate variability	baseline and 8 weeks	It will be evaluated using a previously validated heart rate monitor Polar 810i, and the results will be analyzed in time- and frequency-domains.
Diastolic and mean blood pressure	baseline and 8 weeks	It will be evaluated by 24-hour ambulatory BP monitoring (ABPM)
Functional capacity	baseline and 8 weeks	Evaluate by Six-Minute Walk Test (6MWT)
Respiratory muscle strength	baseline and 8 weeks	The maximal inspiratory and expiratory pressures will be evaluated with manovacuometer
Muscle strength	baseline and 8 weeks	The muscles (quadriceps, gastrocnemius, abdominal and spine extensors) will be evaluated with dynamometer.
Body Mass Index	baseline and 8 weeks	It will be calculated as weight (kg) divided by height squared.
Oxidative damage	baseline and 8 weeks	It will be evaluated by advanced oxidation protein products (AOPP)
Endothelial function	baseline and 8 weeks	By blood analysis (Nitrite measurement/NOx).
Flexibility	baseline and 8 weeks	It will be evaluated by bank of Wells test.
Antioxidant capacity	baseline and 8 weeks	It will be evaluated by total antioxidant capacity (TAC).

Trial Locations

Locations (1)

University Federal of Santa Maria; 🇧🇷 Santa Maria, RS, Brazil